Urokinase receptor-deficient mice mount an innate immune response to and clarify respiratory viruses as efficiently as wild-type mice

References

• Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010; 23:74-98; PMID:20065326; http://dx.doi.org/10.1128/CMR.00032-09
   PubMed Web of Science ®Google Scholar
• Montuori N, Selleri C, Ragno P. The urokinase-receptor in infectious diseases. Infez Med 2012; 20 Suppl 2:13-8; PMID:23042001
   PubMedGoogle Scholar
• Martinez I, Lombardia L, Garcia-Barreno B, Dominguez O, Melero JA. Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J Gen Virol 2007; 88:570-81; PMID:17251576; http://dx.doi.org/10.1099/vir.0.82187-0
   PubMed Web of Science ®Google Scholar
• Plesner T, Ralfkiaer E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, Hansen NE, Danø K. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol 1994; 102:835-41; PMID:7801901
   PubMed Web of Science ®Google Scholar
• Thuno M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009; 27:157-72; PMID:19893210; http://dx.doi.org/10.1155/2009/504294
   PubMed Web of Science ®Google Scholar
• Rijneveld AW, Levi M, Florquin S, Speelman P, Carmeliet P, van Der Poll T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol 2002; 168:3507-11; PMID:11907112; http://dx.doi.org/10.4049/jimmunol.168.7.3507
   PubMed Web of Science ®Google Scholar
• Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 2000; 165:1513-9; PMID:10903758; http://dx.doi.org/10.4049/jimmunol.165.3.1513
   PubMed Web of Science ®Google Scholar
• Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 2003; 33:2090-7; PMID:12884282; http://dx.doi.org/10.1002/eji.200324003
   PubMed Web of Science ®Google Scholar
• Stark JM, McDowell SA, Koenigsknecht V, Prows DR, Leikauf JE, Le Vine AM, Leikauf GD. Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 2002; 67:92-100; PMID:11920822; http://dx.doi.org/10.1002/jmv.2196
   PubMed Web of Science ®Google Scholar
• Chavez-Bueno S, Mejias A, Gomez AM, Olsen KD, Rios AM, Fonseca-Aten M, Ramilo O, Jafri HS. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J 2005; 2:46; PMID:15916706; http://dx.doi.org/10.1186/1743-422X-2-46
   PubMed Web of Science ®Google Scholar
• Hall CB, Douglas RG, Jr., Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 1976; 89:11-5; PMID:180274; http://dx.doi.org/10.1016/S0022-3476(76)80918-3
   PubMed Web of Science ®Google Scholar
• Hirst GK. Studies of Antigenic Differences among Strains of Influenza a by Means of Red Cell Agglutination. J Exp Med 1943; 78:407-23; PMID:19871338; http://dx.doi.org/10.1084/jem.78.5.407
   PubMedGoogle Scholar
• Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S, Gruber AD, Schughart K. Host genetic background strongly influences the response to influenza a virus infections. PLoS One 2009; 4:e4857; PMID:19293935; http://dx.doi.org/10.1371/journal.pone.0004857
   PubMed Web of Science ®Google Scholar
• Graham BS, Perkins MD, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice. J Med Virol 1988; 26:153-62; PMID:3183639; http://dx.doi.org/10.1002/jmv.1890260207
   PubMed Web of Science ®Google Scholar
• Chen H, Zheng D, Abbott J, Liu L, Bartee MY, Long M, Davids J, Williams J, Feldmann H, Strong J, et al. Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection. Antimicrob Agents Chemother 2013; 57:4114-27; PMID:23774438; http://dx.doi.org/10.1128/AAC.02594-12
   PubMed Web of Science ®Google Scholar
• Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol 2007; 82:1212-20; PMID:17704294; http://dx.doi.org/10.1189/jlb.0407251
   PubMed Web of Science ®Google Scholar
• Graziano F, Elia C, Laudanna C, Poli G, Alfano M. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCepsilon. PloS one 2011; 6:e23674; PMID:21858203; http://dx.doi.org/10.1371/journal.pone.0023674
   PubMed Web of Science ®Google Scholar
• Nebuloni M, Zawada L, Ferri A, Tosoni A, Zerbi P, Resnati M, Poli G, Genovese L, Alfano M. HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression. PloS one 2013; 8:e70606; PMID:23923008; http://dx.doi.org/10.1371/journal.pone.0070606
   PubMed Web of Science ®Google Scholar
• Beaufort N, Corvazier E, Mlanaoindrou S, de Bentzmann S, Pidard D. Disruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavage. PLoS One 2013; 8:e75708; PMID:24069438; http://dx.doi.org/10.1371/journal.pone.0075708
   PubMed Web of Science ®Google Scholar
• Sanderson-Smith ML, Zhang Y, Ly D, Donahue D, Hollands A, Nizet V, Ranson M, Ploplis VA, Walker MJ, Castellino FJ. A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. PLoS Path 2013; 9:e1003469; PMID:23853591; http://dx.doi.org/10.1371/journal.ppat.1003469
   PubMed Web of Science ®Google Scholar